市場調査レポート

商品コード

1441281

ヒトミルクオリゴ糖（HMO）の世界市場規模、シェア、成長分析、タイプ別、用途別-産業予測、2023～2030年

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2'-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2023-2030

出版日: 2024年02月17日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のヒトミルクオリゴ糖（HMO）市場規模は、2022年に1億7,791万米ドルと評価され、予測期間中（2024～2031年）にCAGR 9.7%で、2023年の1億9,517万米ドルから2031年までに4億932万米ドルに成長する見込みです。

ヒトミルクオリゴ糖（HMO）市場は、乳児の健康と栄養における重要な成分として脚光を浴びています。複合糖質に分類されるHMOは、ヒト母乳中に天然に存在し、様々な健康上の利点を提供します。これらの生物活性化合物は、乳児の免疫系、胃腸の健康と認知機能の発達をサポートします。HMOの理解が拡大するにつれ、その潜在的応用は乳児栄養学にとどまらず、医療、機能性食品、プレバイオティック・サプリメントのようなセグメントにも広がっています。HMOの健康上の利点に対する一般大衆の意識の高まりと乳児用調製粉乳をより母乳に近づけようという目的は、市場成長の主要促進要因です。免疫学的と腸の健康を強化するHMOの能力は、自然でホリスティックな治療法を求める傾向の高まりと一致します。研究開発には、特定の健康上の利益を対象とする独自のHMO組成の特定と開発も含まれます。しかしながら、特に母乳中に存在する多様なHMOを複製する上で、HMO生産の複雑さとコストに課題が生じる。規制上の考慮と潜在的な知的所有権の障害もまた市場力学に影響を及ぼします。HMOの研究が進むにつれて、市場は乳児栄養だけでなく、さまざまなライフステージにおけるさまざまな健康ニーズへの対応においても有望であることを示しています。栄養と健康の概念を再定義する可能性は、医療と機能性食品の未来を形作る上でのHMO市場の重要性を強調します。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

ヒトミルクオリゴ糖（HMO）の世界市場：タイプ別

市場概要
2'-FLと3-FL
シアリルラクトース
LNTとLNnT

ヒトミルクオリゴ糖（HMO）の世界市場：用途別

市場概要
乳児用調製粉乳
機能性飲食品
食品/医療サプリメント
その他

ヒトミルクオリゴ糖（HMO）の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

DuPont Nutrition & Biosciences
Nestle S.A.
Glycosyn LLC
Jennewein Biotechnologie GmbH
Elicityl
Inbiose
ZuChem Inc.
Glycom A/S
TMO Renewables Ltd.
Abbott Laboratories
Evolve Biosystems
Quantum Biotechnologies Inc.
Novalac
ZuChem Inc.
Clasado Biosciences
Metabiotics Corporation
Medolac Laboratories
HMO Research GmbH
Jennewein Biotechnologie
Holton BioSystems

Product Code: SQMIG30I2309

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031).

The market for human milk oligosaccharides (HMOs) is gaining prominence as a crucial component in infant wellness and nutrition. HMOs, categorized as complex carbohydrates, naturally occur in human breast milk and offer various health benefits. These bioactive compounds support the development of the infant's immune system, gastrointestinal health, and cognitive functions. As our understanding of HMOs expands, their potential applications extend beyond infant nutrition to fields like medicine, functional foods, and prebiotic supplements. Increasing public awareness of the health benefits of HMOs and the aim to make infant formula more akin to breast milk are key drivers of market growth. The ability of HMOs to enhance immunological and gut health aligns with the rising trend of seeking natural and holistic remedies. Research focus also includes identifying and developing unique HMO compositions to target specific health benefits. However, challenges in HMO production complexity and cost arise, particularly in replicating the diverse range of HMOs present in breast milk. Regulatory considerations and potential intellectual property obstacles also influence market dynamics. As research on HMOs advances, the market shows promise not just in infant nutrition but also in addressing various health needs across different stages of life. The potential to redefine the concept of nutrition and well-being underscores the significance of the HMO market in shaping the future of healthcare and functional foods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Milk Oligosaccharides (HMO) and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Human Milk Oligosaccharides (HMO) Market Segmental Analysis

The Human Milk Oligosaccharides (HMO) Market is segmented on the basis of Type, Application, and Region. Based on Type, the market is segmented as, 2'-FL & 3-FL, Sialyllactose, LNT & LNnT. Based on Application the market is segmented as, Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA)

Drivers of the Global Human Milk Oligosaccharides (HMO) Market

The increasing recognition of the health benefits of human milk oligosaccharides (HMOs) is a significant driver for market growth. There is a rising demand for HMO-fortified products due to the role HMOs play in enhancing the immune system, cognitive development, and gut health in infants, as well as potential benefits for adults.

The incorporation of HMOs in formula products reflects consumers' desire for infant formulas that closely mimic the health advantages of breast milk. HMOs have become a vital component of infant nutrition as parents seek to provide their babies with optimal nourishment.

Restraints in the Global Human Milk Oligosaccharides (HMO) Market

The synthesis of HMOs is a challenging and intricate process. The scalability and cost-efficiency of manufacturing HMOs are hindered by the intricate and expensive methods required to replicate the diverse array of HMO structures found in breast milk.

It is essential to educate consumers about the benefits and importance of HMOs, especially in non-infant applications. While challenging, increasing awareness and understanding of the potential uses of HMOs is crucial for market growth.

Market Trends of the Global Human Milk Oligosaccharides (HMO) Market

Exploring Diverse Applications Beyond Infant Nutrition: While HMOs have traditionally been associated with infant feeding and are naturally present in breast milk, there is a growing trend to explore their potential in various other contexts. Researchers are investigating the use of HMOs in functional foods, dietary supplements, and pharmaceuticals to address a range of health conditions across different age groups.

Customization and HMO Profiling: As scientific understanding of HMOs advances, an increasing number of HMO profiles are being developed to closely mimic the composition of HMOs found in the breast milk of specific mothers. This customization offers the potential to provide new-borns with personalized nutrition tailored to their individual needs, as each mother's milk has a unique HMO composition.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Human Milk Oligosaccharides (HMO) Market by Type

Market Overview
2'-FL & 3-FL
Sialyllactose
LNT & LNnT

Global Human Milk Oligosaccharides (HMO) Market by Application

Market Overview
Segmented as
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
and Others

Global Human Milk Oligosaccharides (HMO) Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

DuPont Nutrition & Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glycosyn LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jennewein Biotechnologie GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elicityl
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inbiose
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZuChem Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glycom A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TMO Renewables Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evolve Biosystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantum Biotechnologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novalac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZuChem Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clasado Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabiotics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medolac Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HMO Research GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jennewein Biotechnologie
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holton BioSystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments